SEC Form 4 · accession 0001513162-16-000983
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis H Titterton Jr.
Director
Period of report
Aug 24, 2016
Accepted (ET)
Aug 26, 2016 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 24, 2016 | S | 210,000 | $3.10 | D | 287,437 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The reporting person was no longer a director as of August 24, 2016 (the date of the sale).